DEPLESIA

DEPLESIA  strengthens the kidney, enhances the debility, easing up the blood and
ficilitating the flowing in veins.  As a result of the modern pharmacological research, it proves
that ligustrazine and hirudin is able to stop the effect of thrombase upon the fibrinogen.  It is an
effective anticoagulant. Its thrombolytic effect is remarkable.  It also has the function of lowering
the triglyceride.  DEPLESIA is able to excite the central nervous system, heighten the power of
resisting disease and enhance the vigor of capillary.  Furthermore, it has outstanding efficacy of
vitalizing the heart and protecting the liver.  It has comparatively greater help in the overall recovery
of the entire organism.  Both index of various clinical observation and animal experiment show
that DEPLESIA is not poisonous and not harmful to the human body.  Observation of the animal
experiment finds that DEPLESIA is capable of dilating the blood vessel, reducing the obstruction
of peripheral blood vessel and increasing the mechanism of arterial blood flow. Before and after
the administration of medication, determine the four index of blood rheology.  It shows that
DEPLESIA has the capability to inhibit blood coagulation, reduce blood viscosity, and increase the
blood rate. As a result, the cerebral microcirculation is improved. Thus, it is helpful to accelerate
the establishment of collateral circulation and brings about a better curative effect to the patient of
apoplectic sequel.

Indication: apoplectic sequel, hemiplegia, blood vessel embolism, aphesis, askew mouth and eyes,
etc.